Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H McCabe

Showing results (141-150 of 259) with videos related to

Pageof 26
Sort By:
Journal of the American College of Cardiology|August 18, 2004
Performance of the thrombolysis in myocardial infarction risk index in the National Registry of Myocardial Infarction-3 and -4: a simple index that predicts mortality in ST-segment elevation myocardial infarctionStephen D Wiviott, David A Morrow, Paul D Frederick, et al.
Circulation|January 19, 2000
Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugsC M Gibson, C P Cannon, S A Murphy, et al.
American Heart Journal|April 1, 2009
Thrombolysis in Myocardial Infarction (TIMI) Risk Index predicts long-term mortality and heart failure in patients with ST-elevation myocardial infarction in the TIMI 2 clinical trialQuynh A Truong, Christopher P Cannon, Neil A Zakai, et al.
JAMA|September 19, 2001
Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3D A Morrow, E M Antman, L Parsons, et al.
Cancers|August 12, 2022
Identification of Src as a Therapeutic Target in Oesophageal Adenocarcinoma through Functional Genomic and High-Throughput Drug Screening ApproachesNiamh H McCabe, Leanne Stevenson, Enya Scanlon, et al.
Irish Medical Journal|November 30, 2018
Patterns of mortality in modern stroke careM D'Alton, T Coughlan, N Cogan, et al.
Journal of the American College of Cardiology|November 26, 2002
Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy- Thrombolysis in Myocardial Infarction 18 trial)substudyMarc S Sabatine, David A Morrow, Christopher P Cannon, et al.
Neurology|April 28, 2004
Paraneoplastic "stiff person syndrome" with metastatic adenocarcinoma and anti-Ri antibodiesD J H McCabe, N C Turner, D Chao, et al.
American Heart Journal|September 26, 2006
Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38)Stephen D Wiviott, Elliott M Antman, C Michael Gibson, et al.
Lancet (London, England)|September 1, 2009
Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trialMarc S Sabatine, Elliott M Antman, Petr Widimsky, et al.
Pageof 26

Showing results (141-150 of 259) with videos related to

Sort By:
Pageof 26
Journal of the American College of Cardiology|August 18, 2004
Performance of the thrombolysis in myocardial infarction risk index in the National Registry of Myocardial Infarction-3 and -4: a simple index that predicts mortality in ST-segment elevation myocardial infarctionStephen D Wiviott, David A Morrow, Paul D Frederick, et al.
Circulation|January 19, 2000
Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugsC M Gibson, C P Cannon, S A Murphy, et al.
American Heart Journal|April 1, 2009
Thrombolysis in Myocardial Infarction (TIMI) Risk Index predicts long-term mortality and heart failure in patients with ST-elevation myocardial infarction in the TIMI 2 clinical trialQuynh A Truong, Christopher P Cannon, Neil A Zakai, et al.
JAMA|September 19, 2001
Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3D A Morrow, E M Antman, L Parsons, et al.
Cancers|August 12, 2022
Identification of Src as a Therapeutic Target in Oesophageal Adenocarcinoma through Functional Genomic and High-Throughput Drug Screening ApproachesNiamh H McCabe, Leanne Stevenson, Enya Scanlon, et al.
Irish Medical Journal|November 30, 2018
Patterns of mortality in modern stroke careM D'Alton, T Coughlan, N Cogan, et al.
Journal of the American College of Cardiology|November 26, 2002
Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy- Thrombolysis in Myocardial Infarction 18 trial)substudyMarc S Sabatine, David A Morrow, Christopher P Cannon, et al.
Neurology|April 28, 2004
Paraneoplastic "stiff person syndrome" with metastatic adenocarcinoma and anti-Ri antibodiesD J H McCabe, N C Turner, D Chao, et al.
American Heart Journal|September 26, 2006
Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38)Stephen D Wiviott, Elliott M Antman, C Michael Gibson, et al.
Lancet (London, England)|September 1, 2009
Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trialMarc S Sabatine, Elliott M Antman, Petr Widimsky, et al.
Pageof 26